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ABSTRACT 
 
Purpose: Multifocal ERG is a useful indicator of diabetic retinopathy. The significant 
delay in local responses provides a chance for the detection and understanding of the 
various stages of diabetic retinopathy. Materials and Methods: This is a cross sectional 
study conducted in ERG clinic at M&J Western regional institute of ophthalmology, 
Ahmedabad from January 2013 to September 2015 who were more than 35yrs of age. 
Results: In our study, we studied 45 eyes of diabetic patients and 20 eyes of normal 
subjects. In our study the mean values of the various parameters was calculated in the 
control group with N1, P1 and N2 latency being 14.09ms. 29,76ms and 45.55ms 
respectively. The N1, P1 and N2 amplitude was found to be 31.52nV, 73.61nV and 
90.38nV respectively. The maximum delay in N1, P1 and N2 latency was seen to be 
3.24ms, 7.11ms and 8.40ms respectively from the normal value. We also found a 
decrease in amplitude of the ERG waveform with N1, P1 and N2 amplitude being 
20.98nV,61.48nV and 76.4nV respectively from the normal value. Also it is helpful in 
cases with clinically significant macular edema where responses are remarkably dela yed 
suggesting local retinal dysfunction and macular pathology. It provides us information 
regarding the condition of the macula and some ideas about the extent of ischemia 
affecting this area. Conclusion: In conclusion, we can say that the delayed responses 
obtained indicate abnormal retinal function corresponding to local discrete retinal  
lesions. It provides a very sensitive and objective assessment of the local retinal 
condition in various stages of diabetic retinopathy. 
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INTRODUCTION 
Diabetes Mellitus (DM) is a heterogenous group of metabolic 
disorder characterized by chronic hyperglycemia with 
disturbance of carbohydrate, fat and protein metabolism 
resulting from defect in insulin secretion, insulin action or 
both[1]. The worldwide prevalence of DM has risen 
dramatically over the past two decades, from an estimated 
30 mill ion cases in 1985 to 285 mill ion in 2010. Chronic 
diabetes results in the development of tissue complications, 
mainly microvascular (retinopathy, nephropathy and 
neuropathy) and macrovascular disease (atherosclerosis) [2]. 
Microangiopathy is characterized by progressive occlusion of 
the capillary lumen with subsequent impaired tissue 
perfusion, increased vascular permeability and increased 
production of extracellular material by perivascular cells, 
resulting in basement membrane thickening and loss of 
pericytes [3]. 
Retinopathy is the most common microvascular complication 
of diabetes, and it remains a major cause of new onset 
blindness in age group of 20-74 years of patients worldwide. 
Vascular lesions in the early stages of diabetic retinopathy 
are characterized by the presence of capillary 
microaneurysms, pericyte deficient capillaries, and 
obliterated and degenerated capillaries. Proliferative diabetic 
retinopathy is the more advanced form of the disease, when 
circulation problems cause the retina to become hypoxic. As 
a result, new fragile blood vessels can begin to grow in the 
retina and into the vitreous.  
Electroretinogram (ERG)[4] is the neurophysiological test used 
in order to measure electric changes that happen in the 
retina after a l ight stimulus. Full-field electroretinogram 
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(ERG) has been used as an objective tool to detect alterations 
of retinal function during the early stages of diabetes, to 
predict the progression of diabetic retinopathy and to 
monitor the treatment effects. The sensitivity of the full -field 
ERG is l imited, precisely because it reflects the activity of the 
entire retina. Even advanced disease, if confined to small, 
discrete patches, can remain undetected by the full -field 
ERG. (e.g., focal edema and capillary non perfusion). 
In contrast, the Multifocal  electroretinogram (mfERG) 
developed by Sutter[5] and Tran and Bearse[6] and Sutter  
enables assessment of up to hundreds of distinct retinal 
areas, posterior region around macula within approximately 
8 minutes per eye. 
Aims & Objectives 
Retinopathy is one of the most important complications of 
chronic diabetes. It increases gradually and sometimes seen 
at a very late stage when visual symptoms become obvious 
or when fundus findings are noted. 
Through this study, we would like to assess: 
1. The effect of diabetes on multifocal ERG findings. 
2. The effect of different stages of diabetic retinopathy on 
multifocal ERG findings. 
MATERIALS & METHODS 
Study Design/Place of study: It was a cross sectional study 
Study location: The study was conducted at M & J Western 
Regional institute of Ophthalmology, Ahmedabad from 
January 2013 to September 2015. 
Inclusion criteria: Patients who had mild to moderate non 
proliferative diabetic retinopathy (NPDR) with clinically 
significant macular edema (CSME) age between 35-65 years 
of both sexes. 
Exclusion criteria: Following subjects were excluded from the 
study: History of glaucoma, addiction of alcohol, addiction of 
smoking, retinal detachment due to any reason, Visual acuity 
<6/60 and mentally challenged patients  
Sample Size:  
On the basis of clinical evaluation and fundus examination, 
the subjects were divided into 3 groups - 
GROUP 1: 20 eyes of patients who did not have diabetes 
were taken as control. 
GROUP 2:  25 eyes of patients who had mild to moderate non 
proliferative diabetic retinopathy (NPDR) with clinically 
significant macular edema (CSME). 
GROUP 3:  20 eyes of patients who had severe NPDR with 
CSME. 
Method of data collection: 
The data was collected by means of a personal interview by 
history taking, physical examination and performing the 
tests. The procedure of examination performed was 
explained to all  the cases and written consent was taken 
prior to examination. 
Visual acuity: Taken on Snellen’s chart[7,8]. 
Slit lamp examination: It was done to examine the anterior 
segment as well as fundus using 90 D lense. 
Fundus examination: It was done using slit lamp 
biomicroscopy,direct and indirect ophthalmoscopy. 
Fundus fluorescein angiography: It was also done to 
completely evaluate the vascular system of retina. 
Multifocal electroretinogram: It was done in each patients 
under same condition using ISCEV[9] Standards. 
Classifications and cut-offs parameters 
HBA1C: Patients with HbA1C >6.5 %( 48 mmol/mol) were 
taken as diabetics. 
Fasting and Post Prandial Blood Sugar: Diabetics: Subjects 
with fasting blood sugar >126mg/d1 or >7.0 mmol/1 and post 
prandial blood sugar >200 mg/dl or >11.1 mmol /1 and 
known cases of diabetes irrespective of their current 
treatment status and glycemic control status. All  others were 
considered as non-diabetics. 
Visual Acuity: Subjects with Visual Acuity 6/6 to 6/12 were 
taken in the control group. Visual acuity more than 6/60 
were taken in diabetic group. 
Statistical analysis: The data was analyzed using Microsoft 
excel by applying unpaired t-test for quantitative data and 
using Epi Info 7 version 7.0.8.3 by chi- square test for 
qualitative data . Correlation coefficients and Odds ratio were 
calculated for the different variables. Significance level was 
taken as p < 0.05. 
RESULTS 
Table 1. Age wise distribution of the subjects 
AGE GROUP (Years) GROUP 1 GROUP 2 GROUP 3 
35-45 2 0 1 
45-55 8 11 6 
55-65 10 14 13 
Table 2. Sex wise distribution of subjects 
SEX GROUP 1 GROUP 2 GROUP 3 
MALE 12 10 14 
FEMALE 8 15 6 
 
Figure 1 shows higher values of FBS, PPBS and HbA1C in the 
diabetic group as compared to the control group and the 
difference was found to be statistically significant with the P 
value being less than 0.0001 for all  the parameters. It shows 
a l inear increase in the mean values of FBS, PPBS and HbA1C 
from group 1 to group 3 as the severity of the disease 
increases. 
Comparison of latency and amplitude of erg in 3 groups : A 
mean value of the local responses in multifocal ERG was 
calculated in terms of N1, P1, N2 latencies and amplitudes  of 
all  the subjects and was analyzed. 
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Figure 1. COMPARISON OF FBS(mg/dl) , PPBS (mg/dl) and 
HbA1C (gm%)  in 3 groups 
 
Figure 2. Comparison of p1 implicit time in 3 groups 
 
Figure 2 shows an increase in the P1 implicit time from 
22.63ms in group 1 to 28.59ms in group 2. A further 
increment was noted in group 3 where it is 34.11ms. 
 
 
Figure 3. Comparison of n1 latency in 3 groups. 
 
 
Figure 4. Comparison of n1 amplitude in 3 groups 
Above figures (Figure 3 & 4) show an increase in N1 latency 
of 3.24ms and a decrease in N1 amplitude of 20.98nV from 
group 1 to group 3 suggesting that the latency increases and 
the amplitude increases as the severity of the disease 
increases. 
 
Figure 5. Comparison of p1 latency in 3 groups. 
 
 
Figure 6. Comparison of p1 amplitude in 3 groups 
The figures above (Figure 5 & 6) suggest that the P1 latency 
increases with the difference of 4.56 ms between group 1 
and group 2 and difference of 2.55ms between group 2 and 
group 3. The P1 amplitude decreases significantly with a 
difference of 61.48 between group 1 and group 3. 
 
 
Figure 7. Comparison of n2 latency in 3 groups 
The Figure 7 & 8 show an increase in the N2 latency and a 
decrease in N2 amplitude from group1 to group3. 
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Figure 8. Comparison of n2 amplitude in 3 groups 
DISCUSSION  
Various studies have been done on patient with diabetic 
mellitus correlating the retinal function and potentials with 
severity and duration of diabetes using Multifocal ERG 
technique. Palmowski et al [10], in his study patients 
underwent multifocal ERG testing reporting that implicit 
times of Multifocal  ERGs, averaged across the whole retina, 
were significantly delayed in some diabetic eyes without 
retinopathy. Whole field response delays were greater in 
magnitude and more prevalent among their group eyes with 
NPDR. It was seen that in patients with NPDR, N1 latency was 
delayed (mean=17.1ms), P1 latency (mean=32.3ms) and N1 
amplitude was decreased (mean=19.9nV). In our study in 
severe NPDR, the N1 latency was 17.33ms, P1 latency was 
36.87ms and the N1 amplitude was 10.54nV. Similarly the P1 
implicit time in this study was delayed (27.7ms) which was 
found to be 28.59ms in our study in patients with mild to 
moderate NPDR and further delayed to 34.11ms in severe 
NPDR. 
BRAD FORTUNE et al,[11] 1999, patients with non-proliferative 
diabetic retinopathy (NPDR) and patients without 
retinopathy compared with 16 age-matched, non-diabetic 
subjects found that in eyes with NPDR, the implicit time of 
responses was markedly delayed (e.g., up to 7 mSec from 
normal). 
The results demonstrated that Multifocal ERG[12] implicit time 
analysis is highly sensitive method of assessment of local 
retinal function in diabetics. The range of local ERG implicit 
time observed for the normal eyes in this study was very 
narrow, consistent with the findings of other Multifocal ERG 
studies. Consequently, local ERG delays as small as 2.5mSec 
may be regarded as representing significant local retinal 
dysfunction in diabetic eyes. 
In eyes with NPDR, delays of local responses were greater 
and were found throughout most of the retina than in eyes 
without retinopathy. Response delays were progressively 
worse towards the center of discrete ophthalmoscopic 
lesions in the retinopathic eyes. Local ERGs delayed by 4 
msec or longer were found only in, or immediately adjacent 
to, diabetic retinal lesions. Local ERG amplitudes were more 
variable than implicit times - between normal eyes (10 times ) 
and within normal eyes (5 times). 
In our study the P1 implicit time was delayed by 11.48ms in 
severe NPDR and by 5.96ms in mild-moderate NPDR as 
compared to control. Similarly, the N1 latency delay was 
more than 3ms, N2 and P1 latency delay was more than 7ms 
as concluded by this study. 
YING HAN ET AL,[13] 2004 concluded that the relative risk of 
development of new retinopathy over 1 year in the areas 
with abnormal baseline Multifocal erg implicit times was 
approximately 21 times greater than that in the areas with 
normal baseline Multifocal ergs. Mohamm.ad-sadegh 
farahvash,[14] 2006, studied forty-one eyes with clinically 
significant macular edema, tested and compared with 13 non 
diabetic subjects and found that local electroretinogram 
responses were significantly delayed and decreased in 
amplitude in patients with clinically significant macular 
edema. 
CONCLUSION  
Multifocal ERG is a useful indicator of diabetic retinopathy. 
The significant delay in local responses provide a chance for 
the detection and understanding of the various stages of 
diabetic retinopathy. 
The normal values of the various parameters of mfERG are 
considered to be within a range rather than a discrete value. 
In our study the mean of these values was calculated in the 
control group with N1, P1 and N2 latency being 14.09ms, 
29.76ms and 45.55ms, respectively. The N1, P1 and N2 
amplitude was found to be 31.52nV, 73.61nV and 90.38nV, 
respectively. The maximum delay in N1, P1 and N2 latency 
was seen to be 3.24ms,7.11ms and 8.40ms respectively form 
the normal value. We have also found a decrease in the 
amplitude of the ERG waveform with the N1, P1 and N2 
amplitude being 20.98 nv,61.48nV and 76.4 nV respectively 
from the normal value. Also, it is helpful in cases with 
clinically significant macular edema where the respons es  a re 
remarkably delayed suggesting local retinal dysfunction and 
macular pathology. It provides us information regarding the 
condition of the macula and some idea about the extent of 
ischemia affecting this area. 
In conclusion, we can say that the delayed responses obtained 
indicate abnormal retinal function corresponding to local 
discrete retinopathic lesions. It provides a very sensitive and 
objective assessment of the local retinal condition in various 
stages of diabetic retinopathy. 
REFERENCES 
1. Peter H Bennett, Williams C. Knowler: Joslin's Diabetes 
mellitus, 13th edition. Definition, diagnosis and      
classification of diabetes mellitus and glucose 
homeostasis, chapter 19, 331-339. 
GROUP 1 GROUP 2 GROUP 3
N2 AMPLITUDE 90.38 31.04 13.98
0
20
40
60
80
100
in
 n
V
N2 AMPLITUDE
Int J Clin and Biomed Res. 2017;3(1): 13-17. 
Page 17Amruta Vijay More
 et al.,   
2. International diabetes federation. Global press release for 
world diabetes day. 2012. 
3. Paul Zimmet, Jonathan Shaw: Joslin's Diabetes mellitus, 
13th edition; Diabetes-A world wide problem, chapter 30, 
525-52. 
4. Yonemura D, Aoki T, Tsuzuki K. Electroretinogram in 
diabetic retinopathy. Arch Ophthalmol. 1962;68:19 —24. 
5. Sutter EE, Tran D. The field topography of ERG 
components in man, I: the photopic luminance response. 
Vision Res. 1992;32: 433-446.  
6. Bearse MA, Sutter EE. Imaging localized retinal 
dysfunction with the multifocal electroretinogram. J Opt 
Soc Am A. 1996;13:634- 640. 
7. Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, 
Tormene AP (2010) ISCEV standard for clinical visual 
evoked potentials (2009 update). Doc Ophthalmol 
120:111–119 
8. "Visual acuity measurement standard" (PDF). 
www.icoph.org. Retrieved 2015-05-29. 
9. Donald CH, Michael B (for the International Society For 
Clinical Electrophysiology of Vision). Standard for Clinical 
electroretinography (2011 update). Doc Ophthalmol. 
2012 124:1-13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10. Palmowski AM, Sutter EE, Bearse MA, Fung W. Mapping 
of retinal function in diabetic retinopathy using the 
multifocal electroretinogram. Invest Ophthalmol Vis Sci. 
1997;38:2586-2596 
11. Brad Fortune, Multifocal Electroretinogram Delays Reveal 
Local Retinal Dysfunction in Early Diabetic Retinopathy 
Investigative Ophthalmology & Visual Science. 1999; 
Vol.40, 2638-2651  
12. Seeliger MW, Kretschmann UH, Apfelstedt—Sylla E, 
Zrenner E. Implicit time topography of multifocal 
electroretinograms. InvestbOphthalmol Vis Sci. 
1998;39:718-723. 
13. Ying Han, Anthony J. Adams Multifocal Electroretinogram 
Delays Predict Sites of Subsequent Diabetic Retinopathy 
Investigative Ophthalmology & Visual Science. 
2004;45(3), 948-954.  
14. Mohammad-Sadegh Farahvash, Shiva Mohammadzadeh 
Pharm D. Multifocal eJectroretinogram in clinically 
significant diabetic macular edema, Arch Iranian Med. 
2006; 9 (3): 261 — 265.  
 
Int J Clin and Biomed Res. 2017;3(1): 13-17.
